{"disease":{"id":"pathological-response","name":"pathological response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06630481","title":"Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade","phase":"","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT07181850","title":"Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features","phase":"","overall_status":"COMPLETED","enrollment_count":363,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT07509632","title":"Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":320,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07088354","title":"Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT02800317","title":"RISAS Procedure in Node Positive Breast Cancer Following NAC","phase":"NA","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03038256","title":"Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":244,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03349177","title":"Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Zhiyong Yu","has_results":false},{"nct_id":"NCT03742063","title":"Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone","phase":"","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05925751","title":"Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT03909776","title":"Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06035471","title":"Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":75,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04815694","title":"THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07500129","title":"Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Atlas University","has_results":false},{"nct_id":"NCT04293796","title":"Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"N.N. Petrov National Medical Research Center of Oncology","has_results":false},{"nct_id":"NCT05512481","title":"Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT07127497","title":"Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Anhui Medical University","has_results":false},{"nct_id":"NCT04848454","title":"Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT07430579","title":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false},{"nct_id":"NCT05503108","title":"Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer","phase":"PHASE3","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Leiden University Medical Center","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}